Leigh Anne Siino on The Spherix Global’s Translation of ASH25 Insights Into Actionable Intelligence
Leigh Anne Siino, Chief Revenue Officer at Spherix Global Insights, shared on LinkedIn:
”The Spherix Global Insights Hematology/Oncology team is translating key insights from ASH25 into actionable intelligence — helping strategy, commercial, and medical teams across pharma prepare for the next wave of change across benign and malignant hematology.
What we’re seeing and why it matters now:
Sickle Cell Disease: Turning Patient Voice and Data Into Advantage
SCD is entering a pivotal period, with growing emphasis on coordinated patient-level data and deeper incorporation of patient perspectives.
As pipelines advance and treatment options expand, organizations with timely, centralized insights will be best positioned to optimize targeting, prepare for launches, and align strategies with real-world care delivery.
Cross-Therapeutic Mechanisms and Gene Therapy in Benign Hematology
ASH underscored rising interest in therapies with shared mechanisms across conditions — including autoimmune cytopenias, SCD, hemophilia, and vWD — alongside continued focus on gene therapies.
These dynamics reinforce the need for cross-therapy intelligence to support faster, evidence-based decision-making as indications evolve.
Malignant Hematology: Next-Gen Modalities and Earlier-Line Opportunity
In malignant disease, advances in CAR-T platforms, expanding AML pipelines, and movement into earlier lines (including smoldering multiple myeloma) are reshaping both clinical and commercial landscapes.
Explore our latest and upcoming hematology publications on the Spherix Client Portal.”
All from ASH25 featured in Hemostasis Today.
-
Jan 5, 2026, 15:33Mona Ahmed on Why Some Calcified Nodules Trigger ACS and Others Do Not
-
Jan 5, 2026, 14:17Abdul Mannan – VWF:RCo for Diagnosing von Willebrand Disease: That Test Might Be Failing Your Patients
-
Jan 5, 2026, 13:57Ewang Yemi: CAD is Real and Dangerous – Keep Your Heart Beating
-
Jan 5, 2026, 13:42Dr. Martha Boeckenfeld Shares VetiGel Creation Experiment: How A 17-Year-Old Mixed Algae in a Small Hidden Lab
-
Jan 5, 2026, 12:55Chokri Ben Lamine Explains Washed PRBCs!
-
Jan 5, 2026, 12:30ASH: Be Part of The Next Cohort of Hematology Quality Improvement Leaders
-
Jan 5, 2026, 09:59WFH Released New Evidence-Based Guidelines on AAV Gene Therapy for Hemophilia
-
Jan 5, 2026, 09:51Pete Stibbs: We Still Tend to Talk About VTE Like It’s a Plumbing Problem
-
Jan 5, 2026, 09:40Christopher Pittman on Treating Varicose Veins Before Knee or Hip Replacement